Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mohammad S. Sadaghiani"'
Autor:
Mohammad S. Sadaghiani, Sara Sheikhbahaei, Abdullah Al-Zaghal, Lilja B. Solnes, Martin G. Pomper, Jorge D. Oldan, Gary A. Ulaner, Michael A. Gorin, Steven P. Rowe
Publikováno v:
Tomography, Vol 9, Iss 4, Pp 1504-1514 (2023)
[18F]DCFPyL is increasingly used for prostate-specific membrane antigen (PSMA) mediated imaging of men with biochemically recurrent prostate cancer (BRPCa). In this meta-analysis, which is updated with the addition of multiple new studies, including
Externí odkaz:
https://doaj.org/article/49752aa0379a4ca6a80fbb85514524d1
Autor:
Kevin H. Leung, Steven P. Rowe, Jeffrey P. Leal, Saeed Ashrafinia, Mohammad S. Sadaghiani, Hyun Woo Chung, Pejman Dalaie, Rima Tulbah, Yafu Yin, Ryan VanDenBerg, Rudolf A. Werner, Kenneth J. Pienta, Michael A. Gorin, Yong Du, Martin G. Pomper
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Background Accurate classification of sites of interest on prostate-specific membrane antigen (PSMA) positron emission tomography (PET) images is an important diagnostic requirement for the differentiation of prostate cancer (PCa) from foci
Externí odkaz:
https://doaj.org/article/b41941de8d2b40b8a18526ea80bd1b9d
Autor:
Yujie Wang, Mohammad S. Sadaghiani, Fan Tian, Kathryn C. Fitzgerald, Lilja Solnes, Scott D. Newsome
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: To report clinical characteristics and fluorodeoxyglucose positron emission tomography (FDG-PET) findings in the brain and muscles of individuals with stiff person syndrome (SPS) spectrum disorders (SPSSDs).Methods: Retrospective cohort st
Externí odkaz:
https://doaj.org/article/b42c1f11715d468f96ff4b75ea91ccb1
Autor:
Mohammad S. Sadaghiani, Sara Sheikhbahaei, Rudolf A. Werner, Kenneth J. Pienta, Martin G. Pomper, Michael A. Gorin, Lilja B. Solnes, Steven P. Rowe
Publikováno v:
The Prostate. 82:826-835
Autor:
Sara, Sheikhbahaei, Charles V, Marcus, Mohammad S, Sadaghiani, Steven P, Rowe, Martin G, Pomper, Lilja B, Solnes
Publikováno v:
AJR. American journal of roentgenology. 218(6)
The introduction of immunotherapy with immune-checkpoint inhibitors (ICIs) has revolutionized cancer treatment paradigms. Since FDA approval of the first ICI in 2011, multiple additional ICIs have been approved and granted marketing authorization, an
Autor:
Alireza R; Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical sciences, Tehran, Iran., Mohammad SS, Mehrzad M, Houman A
Publikováno v:
Iranian journal of pediatrics [Iran J Pediatr] 2013 Feb; Vol. 23 (1), pp. 121-3.